Note D - Stock-Based Compensation

3 Months Ended

Mar. 31, 2015

Disclosure Text Block Supplement [Abstract]

Compensation and Employee Benefit Plans [Text Block]

NOTE D: STOCK BASED COMPENSATION

The Company maintains a stock option plan under which incentive stock options, nonqualified stock options and other stock awards may be granted. On March 2, 2006, the Company’s Board of Director’s adopted, and stockholders later approved, the 2006 Stock Option Plan (the “2006 Plan”). Under the 2006 Plan 750,000 shares were reserved for the issuance of stock options to directors, officers, key employees and others. The option exercise price under the 2006 Plan is the fair market value of the stock on the date the option is granted. The fair market value is determined by the closing price of the Company’s common stock, on its primary exchange, on the same date that the option is granted. On March 13, 2014, the Company’s Board of Directors adopted and on May 29, 2014, our shareholders approved, the 2014 Amended and Restated Stock Option and Incentive Plan (the “2014 Plan”) which replaced the 2006 Plan. The shares which remained reserved under the 2006 Plan were transferred to the 2014 Plan and are reserved for the issuance of stock awards to directors, officers, key employees, and others. Stock option exercise price under the 2014 Plan is the fair market value of the stock on the date the option is granted. The restricted stock purchase price under the 2014 Plan shall not be less than 85% of the fair market value of the Company’s common stock on the date the award is made. The fair market value is determined by the average of the highest and lowest sales prices for a share of the Company’s common stock, on its primary exchange, on the same date that the option or award is granted.

Outstanding nonqualified stock options at March 31, 2015, must be exercised within either five or ten years from the date of grant. Nonqualified stock options granted to members of the Company’s Board of Directors vest immediately while nonqualified stock options issued to employees vest in increments of 20% each year.

During the first three months of 2015, 1,225 shares of common stock were granted to non-employee directors under the 2014 Plan. This stock award has a grant date fair value of $57.27 per share, based on the closing price of the Company’s stock on the date of grant, and vests immediately.

The total grant date fair value of stock and stock options vested during the first three months of 2015 was approximately $70,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first three months of 2015 was approximately $119,000 and includes approximately $70,000 recognized as a result of the grant of 175 shares to each non-employee director during the first quarter of 2015. The recognition of stock-based compensation expense decreased diluted and basic earnings per common share by approximately $0.01 during the three months ended March 31, 2015. As of March 31, 2015, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $492,000 which is being amortized on a straight-line basis over the remaining vesting period. As a result, the Company expects to recognize approximately $148,000 in additional compensation expense related to unvested option awards during the remainder of 2015 and to recognize approximately $167,000, $109,000, and $68,000 in additional compensation expense related to unvested option awards during the years 2016, 2017, and 2018, respectively.

The total grant date fair value of stock and stock options vested during the first three months of 2014 was approximately $60,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first three months of 2014 was approximately $86,000 and includes approximately $60,000 recognized as a result of the grant of 504 shares to each non-employee director during the first quarter of 2014. The recognition of stock-based compensation expense decreased diluted and basic earnings per common share by approximately $0.01 during the three months ended March 31, 2014. As of March 31, 2014, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $321,000 which is being amortized on a straight-line basis over the remaining vesting period.

Information related to stock option activity for the three months ended March 31, 2015 is as follows:

	Shares Under Options			Weighted-Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value*
				(per share)		(in years)
Outstanding-January 1, 2015		86,348		$	11.09
Granted		-			-
Exercised		(4,000	)		14.32
Cancelled/forfeited/expired		-			-
Outstanding at March 31, 2015		82,348		$	10.94		5.3	$	3,815,593
Exercisable at March 31, 2015		34,239		$	10.92		2.9	$	1,586,926

___________________________

* The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The per share market value of our common stock, as determined by the closing price on March 31, 2015, was $57.27.

A summary of the status of the Company’s nonvested options and restricted stock as of March 31, 2015 and changes during the three months ended March 31, 2015, is presented below:

Stock Options:

	Number of Options		Weighted- Average Grant Date Fair Value
Nonvested at January 1, 2015		48,109	$	6.10
Granted		-		-
Canceled/forfeited/expired		-		-
Vested		-		-
Nonvested at March 31, 2015		48,109	$	6.10

Restricted Stock:

	Number of Options			Weighted- Average Grant Date Fair Value
Nonvested at January 1, 2015		7,600		$	42.65
Granted		1,225			57.27
Canceled/forfeited/expired		-			-
Vested		(1,225	)		57.27
Nonvested at March 31, 2015		7,600		$	42.65

The number, weighted average exercise price and weighted average remaining contractual life of options outstanding as of March 31, 2015 and the number and weighted average exercise price of options exercisable as of March 31, 2015 are as follows:

Exercise Price		Shares Under Outstanding Options		Weighted-Average Remaining Contractual Term		Shares Under Exercisable Options
				(in years)
$	10.44		15,000		2.9		15,000
$	10.90		6,000		2.2		6,000
$	10.90		41,400		7.2		-
$	11.22		11,948		5.7		5,239
$	11.54		4,000		1.9		4,000
$	11.75		4,000		0.9		4,000
			82,348		5.3		34,239

Cash received from option exercises totaled approximately $57,000 and $187,000 during the three months ended March 31, 2015 and March 31, 2014, respectively. The Company issues new shares upon option exercise.